Barinthus Biotherapeutics
BRNS
15 hedge funds and large institutions have $21.3M invested in Barinthus Biotherapeutics in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 15 → 15 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.32% less ownership
Funds ownership: 25.24% → 24.92% (-0.32%)
42% less capital invested
Capital invested by funds: $36.6M → $21.3M (-$15.2M)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JHU
Johns Hopkins University
Baltimore,
Maryland
|
+$40.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Baird Financial Group
Milwaukee,
Wisconsin
|
-$80.7K |
| 2 |
Morgan Stanley
New York
|
-$56.7K |
| 3 |
Renaissance Technologies
New York
|
-$5.64K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MGP
1
M&G plc
London,
United Kingdom
| $10.4M | +$14.7M | +5,197,349 | New |
|
|
HH
2
HSG Holding
Na,
Hong Kong
| $3.62M | – | – | – |
|
|
AI
3
Alphabet Inc
Mountain View,
California
| $3.6M | – | – | – |
|
|
DF
4
DC Funds
Mclean,
Virginia
| $1.53M | – | – | – |
|
|
BCM
5
BlueCrest Capital Management
St Helier,
Jersey
| $1.29M | – | – | – |
|
|
6
Baird Financial Group
Milwaukee,
Wisconsin
| $399K | -$80.7K | -28,591 | -15% |
|
|
JHU
7
Johns Hopkins University
Baltimore,
Maryland
| $291K | +$40.3K | +14,269 | +13% |
|
|
8
Renaissance Technologies
New York
| $66K | -$5.64K | -1,999 | -7% |
|
|
IIM
9
Ipswich Investment Management
Beverly,
Massachusetts
| $54.9K | – | – | – |
|
10
Janney Montgomery Scott
Philadelphia,
Pennsylvania
| $36K | – | – | – |
|
|
11
Morgan Stanley
New York
| $30.6K | -$56.7K | -20,072 | -61% |
|
12
Geode Capital Management
Boston,
Massachusetts
| $27.8K | – | – | – |
|
13
UBS Group
Zurich,
Switzerland
| $3.68K | – | – | – |
|
|
NECFA
14
New England Capital Financial Advisors
Meriden,
Connecticut
| $248 | – | – | – |
|
15
RhumbLine Advisers
Boston,
Massachusetts
| $144 | – | – | – |
|
BRNS Hedge Fund Activity: Q1 2024 in Review
15 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Barinthus Biotherapeutics (BRNS) for Q1 2024, worth a combined $21.3M — down 42% from $36.6M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new BRNS positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Johns Hopkins University, adding an estimated $40.3K. The largest seller was Baird Financial Group, cutting an estimated $80.7K.
- 15 institutional investors held Barinthus Biotherapeutics (BRNS) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $21.3M of Barinthus Biotherapeutics stock for Q1 2024, down 42% quarter-over-quarter.
- 1 fund opened new Barinthus Biotherapeutics positions in Q1 2024 and 0 closed out, a net change of +1 holder.
- The largest Barinthus Biotherapeutics buyer in Q1 2024 was Johns Hopkins University, an estimated $40.3K added.
- The largest Barinthus Biotherapeutics seller in Q1 2024 was Baird Financial Group, an estimated $80.7K sold.
Based on aggregated 13F filings for Q1 2024.